Journal Features Interpretation - International Journal of Pharmaceutical Sciences and Therapeutic Innovation

IJPSTI is an international core academic journal focusing on pharmaceutical sciences and therapeutic innovation. With the core positioning of "full-chain coverage, interdisciplinary integration, and innovation-oriented leadership", it fully connects the complete academic system from the source of drug research and development to the terminal of clinical application. It builds an efficient academic exchange and achievement transformation platform for researchers, clinicians, industry experts and regulatory authorities in the global pharmaceutical sciences, therapeutics and related fields.

Core Feature 1: Full-Chain Coverage, Connecting the Entire Process of Drug R&D and Therapeutic Application

The journal covers the entire industrial chain of pharmaceutical sciences and therapeutic innovation, from molecular-level drug design to the optimization of treatment plans in clinical practice. The core scope includes: molecular drug design and synthesis, medicinal chemistry, pharmaceutics (formulation research and optimization), pharmaceutical analysis and quality control, pharmacology (pharmacodynamics, pharmacokinetics), toxicology, drug metabolism, clinical pharmacology, therapeutics (disease-targeted therapy, personalized therapy), pharmacoepidemiology, pharmacoeconomics, etc., realizing full-process academic coverage of "basic R&D - clinical transformation - clinical application - regulatory evaluation".

Core Feature 2: Focus on Cutting-Edge Fields, Leading the Innovation Direction of Pharmaceutical Sciences

Following the cutting-edge trends in the global pharmaceutical industry and therapeutics field, it focuses on and prioritizes the collection of cutting-edge research directions, including but not limited to: nanomedicines and drug delivery systems, biosimilars R&D and evaluation, pharmacogenomics and personalized therapy, AI/machine learning-driven drug discovery and design, gene therapy and cell therapy, antibody drugs and biopharmaceuticals, new drug delivery technologies (such as sustained-release, targeted, transdermal absorption, etc.), R&D of therapeutic drugs for rare diseases, R&D of anti-infective drugs and vaccines, etc., helping researchers seize the commanding heights of field innovation.

Core Feature 3: Interdisciplinary Integration, Strengthening Industry-University-Research-Application Collaborative Innovation

Breaking the barriers of a single discipline, it encourages in-depth interdisciplinary integration of pharmaceutical sciences with biomedicine, chemical engineering, artificial intelligence, big data, materials science, clinical medicine, public health, regulatory science and other disciplines. The journal focuses on collecting interdisciplinary research results that can solve practical industry problems, such as: AI-assisted drug target screening and optimization, application of new biomaterials in drug delivery, drug safety evaluation based on big data, evidence-based optimization of clinical treatment plans, etc., promoting collaborative innovation between academia and industry, and accelerating the transformation of scientific research results into clinical applications and industrialization.

Core Feature 4: High-Impact Positioning, Assisting Academic Value and Industrial Upgrading

With the goal of “enhancing academic influence and supporting industry development”, it strictly controls the academic quality of manuscripts and sets up an editorial board composed of top experts in the global field to ensure the professionalism and fairness of the review process. Through the open access (OA) publishing model, the journal maximizes the global dissemination and accessibility of research results, helping authors improve their academic influence and citation potential. At the same time, the journal closely aligns with the development needs of the global pharmaceutical industry and regulatory policy orientation, providing authoritative academic references for drug R&D enterprises, clinical institutions and regulatory authorities, supporting the innovative upgrading of the pharmaceutical industry and the continuous improvement of therapeutic levels, and laying a solid foundation for long-term indexing in core databases such as WoS.

We sincerely invite researchers, clinicians, industry experts and students in the global pharmaceutical sciences, therapeutics and related interdisciplinary fields to submit enthusiastically, and work together to build a world-class international academic exchange platform in the field of pharmaceutical sciences and therapeutic innovation!